Key result
Depletion of RIPK3 or interference with RIPK3 expression alleviated cardiac insufficiency, CaMKII activation, and necroptosis in transverse arch constriction-induced heart failure mice.
Why the study?
To investigate the effect of RIPK3-regulated CaMKII on necroptosis in heart failure and its underlying mechanism.
Does RIPK3 depletion alleviate necroptosis and cardiac dysfunction in a mouse model of transverse arch constriction-induced heart failure?
Does RIPK3 depletion alleviate necroptosis and cardiac dysfunction in a mouse model of transverse arch constriction-induced heart failure?
RIPK3 depletion alleviates cardiac dysfunction and necroptosis in a mouse model of pressure overload-induced heart failure by reducing CaMKII activation.
RIPK3 depletion may mitigate pressure-overload HF in mice; leaves open clinical translation of necroptosis inhibition.
Some studies have reported that the activation of Ca 2+ /calmodulin dependent protein kinase (CaMKII) plays a vital role in the pathogenesis of cardiovascular disease. Moreover, receptor interacting protein kinase 3 (RIPK3)-mediated necroptosis is also involved in the pathological process of various heart diseases. In the present study, we aimed to investigate the effect of RIPK3-regulated CaMKII on necroptosis in heart failure (HF) and its underlying mechanism. Wild type (WT) and RIPK3-depleted (RIPK3 –/– ) mice were treated with transverse arch constriction (TAC). After 6 weeks, echocardiography, myocardial injury, CaMKII activity, necroptosis, RIPK3 expression, mixed lineage kinase domain-like protein (MLKL) phosphorylation, and mitochondrial ultrastructure were measured. The results showed that TAC aggravated cardiac dysfunction, CaMKII activation, and necroptosis in WT mice. However, depletion of RIPK3 alleviated cardiac insufficiency, CaMKII activation, and necroptosis in TAC-treated mice. To verify the experimental results, WT mice were transfected with AAV-vector and AAV-RIPK3 shRNA, followed by TAC operation. The findings were consistent with the expected results. Collectively, our current data indicated that the activation of CaMKII, MLKL and necroptosis in HF mice were increased in a RIPK3-dependent manner, providing valuable insights into the pathogenesis and treatment strategy of HF.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2022) studied Heart failure. RIPK3 depletion or AAV-RIPK3 shRNA vs. Wild type or AAV-vector was evaluated on Cardiac function (EF, FS) and necroptosis markers. Depletion of RIPK3 or interference with RIPK3 expression alleviated cardiac insufficiency, CaMKII activation, and necroptosis in transverse arch constriction-induced heart failure mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: